Agomelatine improves symptom severity and quality of life in diarrhea-predominant irritable bowel syndrome: insights from a randomized controlled clinical trial.
Seyed Saman Talebi, Davoud Ahmadimoghaddam, Mahtabalsadat Mirjalili et al.Naunyn-Schmiedeberg's archives of pharmacology